Antistress effects of Kampo medicine "Yokukansan" via regulation of orexin secretion
Haruto Katahira,1 Masataka Sunagawa,1 Daishi Watanabe,1,2 Yasuaki Kanada,1,3 Ayami Katayama,1 Risa Yamauchi,1 Masashi Takashima,4 Shintaro Ishikawa,1 Tadashi Hisamitsu1 1Department of Physiology, 2Department of Neurology, School of Medicine, Showa University, 3Department of Surgery, Showa Universit...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/780d5d6ff5e544309f2ee0135f409148 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:780d5d6ff5e544309f2ee0135f409148 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:780d5d6ff5e544309f2ee0135f4091482021-12-02T03:35:23ZAntistress effects of Kampo medicine "Yokukansan" via regulation of orexin secretion1178-2021https://doaj.org/article/780d5d6ff5e544309f2ee0135f4091482017-03-01T00:00:00Zhttps://www.dovepress.com/antistress-effects-of-kampo-medicine-quotyokukansanquot-via-regulation-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Haruto Katahira,1 Masataka Sunagawa,1 Daishi Watanabe,1,2 Yasuaki Kanada,1,3 Ayami Katayama,1 Risa Yamauchi,1 Masashi Takashima,4 Shintaro Ishikawa,1 Tadashi Hisamitsu1 1Department of Physiology, 2Department of Neurology, School of Medicine, Showa University, 3Department of Surgery, Showa University Koto Toyosu Hospital, Tokyo, 4Department of Orthopaedic Surgery, Showa University Fujigaoka Hospital, Kanagawa, Japan Objective: Various stressors induce stress responses through the hypothalamic–pituitary–adrenal and the sympathetic–adrenal–medullary axes, which are regulated, in part, by orexin. For example, secretion of orexin in the hypothalamus is increased in rats exposed to the stress of social isolation for 1 week. In this study, the antistress effects of Kampo medicine Yokukansan (YKS) via the regulation of orexin secretion were investigated using a rat model.Methods and results: The administration of 300 mg/kg per day of YKS to rats for 1 week significantly decreased the plasma orexin levels compared with non-treated rats, whereas the administration of 1,000 mg/kg of YKS had no effect on orexin levels. Therefore, 300 mg/kg of YKS was an effective dose for controlling orexin secretion. Subsequently, rats were divided into group-housed control (Con), individually housed stress (Stress), and individually housed YKS (300 mg/kg)-treated stress (Stress + YKS) groups. After 1 week, a resident–intruder aggression test was performed, and the plasma levels of orexin and corticosterone were measured. In the Stress group, aggressive behavior and the levels of corticosterone and orexin significantly increased compared with the Con group; however, these effects were inhibited in the Stress + YKS group. Further, an orexin receptor antagonist (TCS 1102; 10 mg/kg) was intraperitoneally administered to rats exposed to isolation stress to determine whether orexin was involved in stress responses. Under these conditions, aggressive behavior and the level of corticosterone significantly decreased compared with the Stress group.Conclusion: These results suggest that orexin is involved in the control of stress response and that YKS exerts an antistress effect via the regulation of orexin secretion. Keywords: Yokukansan, orexin, antistress effect, social isolation stress, corticosterone, aggressive behaviorKatahira HSunagawa MWatanabe DKanada YKatayama AYamauchi RTakashima MIshikawa SHisamitsu TDove Medical PressarticleYokukansanorexinanti-stress effectsocial isolation stresscorticosteroneaggressive behaviorNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 13, Pp 863-872 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Yokukansan orexin anti-stress effect social isolation stress corticosterone aggressive behavior Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 |
spellingShingle |
Yokukansan orexin anti-stress effect social isolation stress corticosterone aggressive behavior Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Katahira H Sunagawa M Watanabe D Kanada Y Katayama A Yamauchi R Takashima M Ishikawa S Hisamitsu T Antistress effects of Kampo medicine "Yokukansan" via regulation of orexin secretion |
description |
Haruto Katahira,1 Masataka Sunagawa,1 Daishi Watanabe,1,2 Yasuaki Kanada,1,3 Ayami Katayama,1 Risa Yamauchi,1 Masashi Takashima,4 Shintaro Ishikawa,1 Tadashi Hisamitsu1 1Department of Physiology, 2Department of Neurology, School of Medicine, Showa University, 3Department of Surgery, Showa University Koto Toyosu Hospital, Tokyo, 4Department of Orthopaedic Surgery, Showa University Fujigaoka Hospital, Kanagawa, Japan Objective: Various stressors induce stress responses through the hypothalamic–pituitary–adrenal and the sympathetic–adrenal–medullary axes, which are regulated, in part, by orexin. For example, secretion of orexin in the hypothalamus is increased in rats exposed to the stress of social isolation for 1 week. In this study, the antistress effects of Kampo medicine Yokukansan (YKS) via the regulation of orexin secretion were investigated using a rat model.Methods and results: The administration of 300 mg/kg per day of YKS to rats for 1 week significantly decreased the plasma orexin levels compared with non-treated rats, whereas the administration of 1,000 mg/kg of YKS had no effect on orexin levels. Therefore, 300 mg/kg of YKS was an effective dose for controlling orexin secretion. Subsequently, rats were divided into group-housed control (Con), individually housed stress (Stress), and individually housed YKS (300 mg/kg)-treated stress (Stress + YKS) groups. After 1 week, a resident–intruder aggression test was performed, and the plasma levels of orexin and corticosterone were measured. In the Stress group, aggressive behavior and the levels of corticosterone and orexin significantly increased compared with the Con group; however, these effects were inhibited in the Stress + YKS group. Further, an orexin receptor antagonist (TCS 1102; 10 mg/kg) was intraperitoneally administered to rats exposed to isolation stress to determine whether orexin was involved in stress responses. Under these conditions, aggressive behavior and the level of corticosterone significantly decreased compared with the Stress group.Conclusion: These results suggest that orexin is involved in the control of stress response and that YKS exerts an antistress effect via the regulation of orexin secretion. Keywords: Yokukansan, orexin, antistress effect, social isolation stress, corticosterone, aggressive behavior |
format |
article |
author |
Katahira H Sunagawa M Watanabe D Kanada Y Katayama A Yamauchi R Takashima M Ishikawa S Hisamitsu T |
author_facet |
Katahira H Sunagawa M Watanabe D Kanada Y Katayama A Yamauchi R Takashima M Ishikawa S Hisamitsu T |
author_sort |
Katahira H |
title |
Antistress effects of Kampo medicine "Yokukansan" via regulation of orexin secretion |
title_short |
Antistress effects of Kampo medicine "Yokukansan" via regulation of orexin secretion |
title_full |
Antistress effects of Kampo medicine "Yokukansan" via regulation of orexin secretion |
title_fullStr |
Antistress effects of Kampo medicine "Yokukansan" via regulation of orexin secretion |
title_full_unstemmed |
Antistress effects of Kampo medicine "Yokukansan" via regulation of orexin secretion |
title_sort |
antistress effects of kampo medicine "yokukansan" via regulation of orexin secretion |
publisher |
Dove Medical Press |
publishDate |
2017 |
url |
https://doaj.org/article/780d5d6ff5e544309f2ee0135f409148 |
work_keys_str_mv |
AT katahirah antistresseffectsofkampomedicinequotyokukansanquotviaregulationoforexinsecretion AT sunagawam antistresseffectsofkampomedicinequotyokukansanquotviaregulationoforexinsecretion AT watanabed antistresseffectsofkampomedicinequotyokukansanquotviaregulationoforexinsecretion AT kanaday antistresseffectsofkampomedicinequotyokukansanquotviaregulationoforexinsecretion AT katayamaa antistresseffectsofkampomedicinequotyokukansanquotviaregulationoforexinsecretion AT yamauchir antistresseffectsofkampomedicinequotyokukansanquotviaregulationoforexinsecretion AT takashimam antistresseffectsofkampomedicinequotyokukansanquotviaregulationoforexinsecretion AT ishikawas antistresseffectsofkampomedicinequotyokukansanquotviaregulationoforexinsecretion AT hisamitsut antistresseffectsofkampomedicinequotyokukansanquotviaregulationoforexinsecretion |
_version_ |
1718401735659094016 |